Mycapssa (Octreotide)

**Product type:** Human Prescription Drug

**Active ingredient:** OCTREOTIDE

**Strength:** 20 mg/1

**Dosage form:** Capsule, Delayed Release

**Route:** Oral

**Labeler:** Chiesi USA, Inc.

**Marketing category:** NDA (NDA208232)

**Pharmacologic class:** Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]